Dr. Ai on the FDA Approval of Mogamulizumab in CTCL

4 Views
administrator
administrator
08/09/23

Wei Z. Ai, MD, hematologist, University of California, San Francisco, discusses the FDA approval of mogamulizumab for the treatment of patients with cutaneous T-cell lymphoma who have received at least 1 prior systemic therapy.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next